Personalis, Inc. Valuation Allowance, Deferred Tax Asset, Increase (Decrease), Amount
Personalis, Inc. (PSNL) reported Valuation Allowance, Deferred Tax Asset, Increase (Decrease), Amount of $11.81 million for the 12-month period ending 2025-12-31, per its 10-K filed 2026-02-26.
Financial Statements › Notes › Income Taxes › Components of Deferred Tax Assets and Liabilities › Components of Deferred Tax Assets
us-gaap:ValuationAllowanceDeferredTaxAssetChangeInAmount · last filed 2026-02-26
- Personalis, Inc. valuation allowance, deferred tax asset, increase (decrease), amount for fiscal 2025 was $11.81M, a 29.87% decline from fiscal 2024.
- Personalis, Inc. valuation allowance, deferred tax asset, increase (decrease), amount for fiscal 2024 was $16.85M, a 44.58% decline from fiscal 2023.
- Personalis, Inc. valuation allowance, deferred tax asset, increase (decrease), amount for fiscal 2023 was $30.40M, a 7.60% decline from fiscal 2022.
- Personalis, Inc. valuation allowance, deferred tax asset, increase (decrease), amount for fiscal 2022 was $32.90M, a 32.66% increase from fiscal 2021.
| Period end | Valuation Allowance, Deferred Tax Asset, Increase (Decrease), Amount 12 month | Valuation Allowance, Deferred Tax Asset, Increase (Decrease), Amount 12 month as first filed |
|---|---|---|
| 2025-12-31 | $11.81M 10-K · filed 2026-02-26 | |
| 2024-12-31 | $16.85M 10-K · filed 2026-02-26 | $16.80M 10-K · filed 2025-02-27 |
| 2023-12-31 | $30.40M 10-K · filed 2025-02-27 | |
| 2022-12-31 | $32.90M 10-K · filed 2024-02-28 | |
| 2021-12-31 | $24.80M 10-K · filed 2023-02-23 | |
| 2020-12-31 | $16.80M 10-K · filed 2022-02-24 | |
| 2019-12-31 | $7.60M 10-K · filed 2021-02-25 | |
| 2018-12-31 | $4.50M 10-K · filed 2020-03-25 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Fortrea Holdings Inc. (FTRE) | United States | $1.903B | -19.43 |
| CASTLE BIOSCIENCES INC (CSTL) | United States | $1.074B | -37.45 |
| Lumexa Imaging Holdings, Inc. (LMRI) | United States | $0.951B | |
| Fulgent Genetics, Inc. (FLGT) | United States | $0.593B | -6.70 |
| CareDx, Inc. (CDNA) | United States | $3.174B | 13.21 |
| BIODESIX INC (BDSX) | United States | $0.312B | |
| EXAGEN INC. (XGN) | United States | $0.212B | -5.95 |
| Freenome, Inc. (FRNM) | United States | $0.143B | |
| SERA PROGNOSTICS, INC. (SERA) | United States | $0.062B | -5.75 |
| AMERICAN SHARED HOSPITAL SERVICES (AMS) | United States | $0.010B | -5.64 |